We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-3.9%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$12.1B
AUM Growth
-$347M
Cap. Flow
+$370M
Cap. Flow %
3.06%
Top 10 Hldgs %
19.18%
Holding
404
New
14
Increased
186
Reduced
117
Closed
17

Top Buys

Rank Stock Value
1
ATR icon
AptarGroup
ATR
+$43.9M
2
DOC
PHYSICIANS REALTY TRUST
DOC
+$39.3M
3
COLM icon
Columbia Sportswear
COLM
+$35.2M
4
MEDP icon
Medpace
MEDP
+$30.8M
5
TRMB icon
Trimble
TRMB
+$29.3M

Top Sells

Rank Stock Value
1
DORM icon
Dorman Products
DORM
+$39.3M
2
CTXS
Citrix Systems Inc
CTXS
+$33.2M
3
MIDD icon
Middleby
MIDD
+$33.2M
4
PNC icon
PNC Financial Services
PNC
+$32.8M
5
AMGN icon
Amgen
AMGN
+$27.1M

Sector Composition

Rank Sector Weight
1 Technology 19.87%
2 Financials 16.58%
3 Healthcare 15.96%
4 Industrials 13.65%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
301
Eli Lilly
LLY
$1T
$655K 0.01%
2,288
-2,030
-47% -$522K
BSV icon
302
Vanguard Short-Term Bond ETF
BSV
$44.6B
$631K 0.01%
8,100
-392
-5% -$31.1K
CBT icon
303
Cabot Corp
CBT
$4.63B
$620K 0.01%
9,059
-100
-1% -$6.6K
QUAL icon
304
iShares MSCI USA Quality Factor ETF
QUAL
$47.1B
$609K 0.01%
4,527
FISV
305
Fiserv Inc
FISV
$29.1B
$598K ﹤0.01%
5,893
DFAC icon
306
Dimensional US Core Equity 2 ETF
DFAC
$48.6B
$594K ﹤0.01%
21,537
BNS icon
307
Scotiabank
BNS
$107B
$592K ﹤0.01%
8,250
-1,825
-18% -$132K
VLY icon
308
Valley National Bancorp
VLY
$8.03B
$567K ﹤0.01%
+43,573
New +$607K
LFUS icon
309
Littelfuse
LFUS
$11.2B
$559K ﹤0.01%
+2,243
New +$595K
BAX icon
310
Baxter International
BAX
$14.6B
$548K ﹤0.01%
7,071
+120
+2% +$10K
EBC icon
311
Eastern Bankshares
EBC
$5.31B
$538K ﹤0.01%
25,000
-2,500
-9% -$53.2K
WBA
312
DELISTED
Walgreens Boots Alliance
WBA
$529K ﹤0.01%
11,812
+350
+3% +$17.2K
CARR icon
313
Carrier Global
CARR
$52B
$528K ﹤0.01%
11,521
+60
+0.5% +$2.83K
STZ icon
314
Constellation Brands
STZ
$22.4B
$511K ﹤0.01%
2,217
MCK icon
315
McKesson
MCK
$99.3B
$510K ﹤0.01%
1,666
BN icon
316
Brookfield
BN
$106B
$506K ﹤0.01%
+16,594
New +$496K
SCHP icon
317
Schwab US TIPS ETF
SCHP
$16.3B
$504K ﹤0.01%
16,592
+1,200
+8% +$36.8K
BSX icon
318
Boston Scientific
BSX
$71.4B
$494K ﹤0.01%
11,150
QQQ icon
319
Invesco QQQ Trust
QQQ
$469B
$481K ﹤0.01%
1,327
BLK icon
320
Blackrock
BLK
$174B
$478K ﹤0.01%
625
SHW icon
321
Sherwin-Williams
SHW
$85.5B
$458K ﹤0.01%
1,833
TRV icon
322
Travelers Companies
TRV
$77.9B
$449K ﹤0.01%
2,455
-218
-8% -$37.4K
OTIS icon
323
Otis Worldwide
OTIS
$27.6B
$448K ﹤0.01%
5,828
SCHW
324
Charles Schwab
SCHW
$184B
$444K ﹤0.01%
5,270
SMFG icon
325
Sumitomo Mitsui Financial
SMFG
$160B
$442K ﹤0.01%
70,525
-475
-0.7% -$3.38K

Similar funds

Boston Trust Walden's Q1 2022 Portfolio in Review

As of Q1 2022, Boston Trust Walden held 404 positions worth $12.1B, down 2.8% from $12.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden deployed $370M of net new capital in Q1 2022, opening 14 new positions and adding to 186 existing holdings. Its largest new stake was VMware, Inc: 42,032 shares worth $4.79M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dorman Products, an estimated $39.3M trimmed.

  • Boston Trust Walden's largest Q1 2022 buy was VMware, Inc: 42,032 shares worth $4.79M.
  • Boston Trust Walden added most to AptarGroup in Q1 2022, an estimated $43.9M increase.
  • Boston Trust Walden's biggest Q1 2022 reduction was Dorman Products, cutting an estimated $39.3M.
  • Boston Trust Walden fully exited IPG Photonics in Q1 2022, selling an estimated $25.4M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $12.1B portfolio in Q1 2022.
  • Boston Trust Walden opened 14 new positions and closed 17 in Q1 2022.
  • Boston Trust Walden's portfolio value fell 2.8% quarter-over-quarter to $12.1B.

Based on Boston Trust Walden's 13F filing for Q1 2022, filed 20 Apr 2022.